2. Page 03 Page 04 Page 05 Page 06 Page 07 Contents We are
delighted to be partnering with Vacancysoft to provide insight on
recruitment activity in the Pharmaceuticals sector. For this report
we have been analysing activity in Q1 across Europe, identifying
key hotspots of activity we are witnessing. I hope you find it
interesting and should you like to know more about current market
activity please do contact me. Yvette Cleland CEO Clinical
Professionals [email protected]
3. Biometrics Analysis Although Biometrics only accounts for 3%
of Swiss scientific vacancies data is starting to suggest a greater
interest in the field from leading companies, particularly within
Bioanalytics. In general terms Biometrics has seen a small increase
over the last year with a relatively flat 3% monthly growth rate.
This has led to a 26% increase in vacancies in the first half of
2015, compared with the last half of 2014 bolstered by a recent
rise in Statistics vacancies. Novartis and Roche have had the vast
majority of openings over the last 12 months accounting for more
than 2/3 (69%) of all vacancies. Novartis on its own has listed
half (50%) of all vacancies showing consistent interest across all
Biometrics roles with a recent focus on Statistics roles between
February and April. Bioanalytics roles have clearly led the way
with 44% of vacancies followed by Biostatisticians with 37%. The
majority are at a Mid Associate / Manager level, 56%, and Senior
Manager level, 27%. Interestingly, however, there have also been a
significant number of senior vacancies at Department / Divisional
Head and Director / Partner level almost entirely within
Bioanalytics. Novartis have been the most active, hiring at all
seniority levels, suggesting they are building a new team, or
significantly bolstering their existing Bioanalytics capabilities.
Biometrics has been a growth area in Switzerland over the last 12
months, with the predominance of roles falling with in the Basel
area. Novartis and Roche have been at the forefront of this growth,
also leading way is Actelion, whose Biometrics operations has grown
with the companies investment into its R&D capabilities. The
Swiss pharmaceuticals companies having the benefit of drawing
talent globally with the UK, France and Germany providing a strong
talent pool of candidates. The key attraction is both the
reputation of the Sponsors and the excellent salaries provided
which has been further increased by the recently strong Swiss
franc. Biometrics Vacancies by Role BIOANALYTICS BIOMETRICIAN
BIOSTATISTIAN STATISTICS Biometrics Vacancies by Seniority MID
ASSOCIATE/MANAGER SENIOR ASSOCIATE/MENEGER DEPARTMENT/DIVISIONAL
HEAD DIRECTOR/PARTNER Biometrics Vacancies Over the Last 12 Months
BIOMETRICS % of SCIENTIFIC TotalVanacies 1 2 3 4 5 6 1 2 3 4 5 6 7
8 9 2014 2015 JAN FEB MAR APR MAY JUNJUL AUG SEP OCT NOV DEC
Novartis AG Roche Vifor Actelion CSL Ltd Biogen Idec Merck Serono
NovImmune Shire Plc Other (4 Companies) Grand Total Total
Biometrics Total Scientic % Biometrics % Company Scientic % Total
Scientic 26 10 3 2 2 1 1 1 1 5 52 331 513 95 56 22 35 45 6 14 N/A
1962 50% 19% 6% 4% 4% 2% 2% 2% 2% 10% 100% 8% 2% 3% 4% 9% 3% 2% 17%
7% N/A 1.3% 0.5% 0.2% 0.1% 0.1% 0.1% 0.1% 0.1% 0.1% N/A 2.7%
VACANCIES
4. Clinical Analysis Clinical vacancies have accounted for 11%
of total scientific vacancies in Switzerland over the last 12
months and with a monthly growth rate of 5.5% is one of the fastest
growing. Clinical Operations and Clinical Projects roles have been
the big drivers over the previous 6 months. Of these Roche posted
just under half (48%) of Operations vacancies with Covance claiming
a similar proportion of Projects roles, illustrating the current
split caused by the rising influence of CROs. This is further
supported by the appearance of 4 CROs in the top 10 companies
advertising Clinical vacancies. Covance leads the way coming in at
number 4. In real terms, however, Roche and Novartis still dominate
the market each accounting for about a quarter of all vacancies. Of
Roche vacancies over half (57%) are equally spread across Clinical
Operations, Studies and Supply. These are closely followed by
Clinical Development, which in terms of the total market has seen
the greatest proportion of vacancies over the last 12 months with
an 18% share. Novartis has been the biggest advertiser of
Development roles accounting for almost 1/3 (29%) of all their
Clinical vacancies. Interestingly close to 80% of these are at a
senior, Department / Divisional Head or Director / Partner level
indicating a possible restructure or the creation of a new
department in this area. Here at Clinical Professionals we have
found that although Novartis & Roche have a very large
percentage of the clinical vacancies on the market, were seeing an
increase in clinical hiring from the slightly smaller companies
such as Actelion & Celgene. CROs are gaining more momentum in
Switzerland at the moment as well, supporting vacancysofts findings
of Covance, PRA, Quintiles & Clintec now all in the top 10
companies advertising clinical vacancies. Finally, weve
historically found that a large majority of roles fall at or above
middle management level, and although this remains true, senior
management level roles are becoming even more common. Clinical
Vacancies Over the Last 12 Months JAN FEB MAR APR MAY JUNJUL AUG
SEP CLINICAL % of SCIENTIFIC OCT TotalVanacies NOV DEC 2014 2015 5
10 15 20 25 30 2 4 6 8 10 12 14 16 18 Clinical Vacancies by
Seniority MID ASSOCIATE/MANAGER SENIOR ASSOCIATE/MENEGER
DEPARTMENT/DIVISIONAL HEAD DIRECTOR/PARTNER JUNIOR
ASSOCIATE/MANAGER Clinicals Vacancies by Role OTHERCLINICAL
DEVELOPMENT CLINICAL OPERATIONS CTA CRA CLINICAL MANAGEMENT
CLINICAL SUPPLIES CLINICAL PROJECTS CLINICAL STUDY CLINICAL DATA
MANAGEMENT STATISTICAL PROGRAMMER Roche Novartis AG Actelion
Covance Takeda Celgene PRA Bayer Quintiles ClinTec Other (22
Companies) Grand Total Total Clinical % Clinical 59 52 18 14 11 9 7
6 6 5 30 217 513 331 56 26 47 48 7 66 16 6 N/A 1962 27% 24% 8% 6%
5% 4% 3% 3% 3% 2% 14% 100% 12% 16% 32% 54% 23% 19% 100% 9% 38% 83%
N/A 3.0% 2.7% 0.9% 0.7% 0.6% 0.5% 0.4% 0.3% 0.3% 0.3% N/A 11.1%
Total Scientic % Company Scientic % Total Scientic VACANCIES
5. Medical Analysis Medical Affairs and Medical Information
vacancies represent about 8% of total Swiss scientific vacancies
from the last 12 months. Out of the four areas covered by this
report Medical vacancies have seen the greatest upward trend with a
Monthly growth rate of 6%, well above the 4% average for scientific
roles. This has led to a 64% increase in the total number of
vacancies in the first half of 2015 compared to the latter half of
2014. Looking at the data in a bit more detail we can see a sharp
increase (71%) in Medical Affairs vacancies in 2015, a quarter of
which posted in February alone. Interestingly a high proportion of
these (40%) are in senior, Department/Divisional Head and
Director/Partner level, positions indicating the potential for
strong future growth. Novartis accounts for the largest proportion
of the market with half (50%) of their total Medical Affairs and
Medical Information vacancies in senior positions and of those
nearly are in Medical Affairs. Other companies also heavily
investing in this area, with large proportions of their total
scientific vacancies, include Takeda (26%), AbbVie (63%), Alexion
(29%) and Shire (29%). Even F Hoffmann-La Roche vacancies have
remained constant bucking the general drop in their scientific
vacancies between the second half of 2014 and first half of 2015.
Inthefirsthalfof2015wehaveseengrowthacrossallareasofMedicalrecruitment
within Switzerland, it is evident across areas within Drug Safety,
Medical Affairs and Clinical Research. Interestingly this is not
only with the larger well known pharma companies but also the
smaller Biotech and fledgling Pharma/Biotech organisations. We have
seen a rise in both permanent and interim vacancies within this
function and the indications are that this will continue into the
remainder of the year. Medical Vacancies Over the Last 12 Months
JAN FEB MAR APR MAY JUNJUL AUG SEP MEDICAL % of SCIENTIFIC OCT
TotalVanacies NOV DEC 2014 2015 5 10 15 20 25 2 4 6 8 10 12 14
Medical Vacancies by Role MEDICAL ADVISOR MEDICAL AFFAIRS MEDICAL
COMMUNICATIONS MEDICAL INFORMATION SCIENTIFIC ADVISOR Medical
Vacancies by Seniority DEPARTMENT/DIVISIONAL HEAD DIRECTOR/PARTNER
JUNIOR ASSOCIATE/MANAGER MID ASSOCIATE/MANAGER SENIOR
ASSOCIATE/MENEGER Novartis AG Roche Takeda Bayer Celgene Vifor
AbbVie Biogen Idec Alexion Pharma UK Shire Other (25 Companies)
Grand Total Total Medical % Medical 34 26 12 8 8 8 5 5 4 4 42 156
331 513 47 66 48 95 8 35 14 14 N/A 1962 22% 17% 8% 5% 5% 5% 3% 3%
3% 3% 27% 100% 10% 5% 26% 12% 17% 8% 63% 14% 29% 29% N/A 1.7% 1.3%
0.6% 0.4% 0.4% 0.4% 0.3% 0.3% 0.2% 0.2% N/A 8.0% Total Scientic %
Company Scientic % Total Scientic VACANCIES
6. QA Analysis Quality Assurance comes a close 2nd to R&D
with over a quarter (26%) of total scientific vacancies posted in
Switzerland over the last 12 months. With a consistent Monthly
growth rate of 5% QA vacancies have seen a 27% increase in the
first half of 2015 compared to the last half of 2014. Perhaps most
impressive is the 84% increase in QC vacancies, which ended up
accounting for about a fifth of the total. A good deal of this
upward pressure has come from companies who have focused much of
their 2015 HR investment in QA roles. These include Johnson and
Johnson with close to half of all their scientific vacancies in QA,
Baxter Healthcare with 70% and Bayer, Merk Serono and Bachem with
around 40%. In real terms, however, Roche is still the main driving
force with 29% of total vacancies. of these, in line with the
broader average across the market, are at Mid Associate / Manager
level, perhaps reflecting the maturity of the field. Interestingly
Novartis, although accounting for 8% of the market, is the only
company in the top 10 with a percentage of vacancies, when compared
to their overall scientific vacancies, below the 26% sector average
at only 12%. This may suggest a hiring strategy focused further up
the product life cycle as seen by their higher than average numbers
in Biometrics, Clinical and Medical. From a staffing perspective,
we have seen an increase in QA roles based in Switzerland, as well
as the rest of Europe, confirming the data from VacancySoft.
Interestingly in the Clinical Professionals salary survey 59% of
all QA candidates surveyed said they would be seeking a new role in
2014/15, 18% said they would consider a new role if the package was
right leaving only 23% of the QA market confirming they would not
be seeking a new position. This may be a resulting consequence of
the 27% increase in vacancies in 2015 in the Swiss QA industry
compared to the end of 2014. QA Vacancies Over the Last 12 Months
JAN FEB MAR APR MAY JUNJUL AUG SEP MEDICAL % of SCIENTIFIC OCT
TotalVanacies NOV DEC 2014 2015 2 4 6 8 10 12 14 QA Vacancies by
Seniority MID ASSOCIATE/MANAGER SENIOR ASSOCIATE/MENEGER
DEPARTMENT/DIVISIONAL HEAD DIRECTOR/PARTNER JUNIOR
ASSOCIATE/MANAGER QA Vacancies by Role IT VALIDATION VALIDATION GMP
OTHER 10 20 30 40 50 60 70 QUALITY ASSURANCE QUALITY CONTROL
COMPLIANCE VALIDATION AUDITOR Roche J&J Novartis AG Vifor Bayer
Baxter Healthcare Merck Serono Celgene Bachem Holding AG Biogen
Idec Other (45 Companies) Grand Total Total QA % QA 147 56 39 33 27
19 18 15 14 10 133 511 513 116 331 95 66 27 45 48 38 35 N/A 1962
29% 11% 8% 6% 5% 4% 4% 3% 3% 2% 26% 100% 29% 48% 12% 35% 41% 70%
40% 31% 37% 29% N/A 7% 3% 2% 2% 1% 1% 1% 1% 1% 1% N/A 26% VACANCIES
Total Scientic % Company Scientic % Total Scientic
7. Clinical Professionals Clinical Professionals is Europes
leading independent life science staffing business offering
outsourced solutions via Functional Service Provision (FSP) and
traditional, high quality staffing solutions. Detailed market
research carried out in early 2013 found that 95% of hiring
managers rate Clinical Professionals as consistently superior in
quality, speed of response, staff retention and communication. In
addition to this, nine out of ten customers rate the company as
their most trusted partner. Clinical Professionals have developed a
highly comprehensive understanding of a broad range of specialist
functional disciplines within the pharmaceutical industry. Our
knowledge-base has its foundations in an unrivalled blend of
industry experience combined with a commitment to investing in
training and development. We have specialist teams dedicated to
recruiting within the various pharmaceutical sectors for permanent,
contract, interim, FSP and freelance vacancies. Clinical
Professionals offer a variety of services for both candidates and
clients, including our CP FSP model, offering clients the
opportunity to outsource the recruitment of a whole team whilst
retaining control of the monitoring function in-house. What we do:
Our Service Capabilities across all European Countries include:
Contingency permanent recruitment Contract recruitment freelance
and PAYE via Clinical Professionals/Only Medics Search and
selection permanent recruitment Specialist project-based interims
via Clinical Professionals/Only Medics FSP outsourced teams across
Europe Clinical Professionals has launched their 2015 European
Salary Survey to determine the salary and benefits for each sector
of the UK Life Science industry. The Survey will analyse salary and
benefits for each sector of the European Life Science industry, and
follows on from the success of our previous pharmaceutical salary
surveys. Contact us for more information on
[email protected] EU Office Ground Floor,
11-12 Bouverie Street, London, EC4Y 8DP t | +44 (0)207 822 1710 UK
Office 33 Blagrave Street, Reading, Berkshire, RG1 1PW t | +44
(0)118 959 4990
